The Global Superficial Radiation Therapy System Market is anticipated to reach a market value of US$ 43.3 Million in 2022 with a CAGR of 3.8%, indicating significant market growth during the forecast period. The market for superficial radiation therapy systems is anticipated to reach US$ 58.2 Million by the end of 2030, with sales revenue …
Category Archives: Healthcare Trends
Veterinary Imaging Market is projected to reach a valuation of US$ 3.37 Billion by 2030 exhibit a CAGR of 6.6%
Over the projected period of 2022–2030, the global Veterinary Imaging Market is anticipated to grow at a CAGR of 6.6%, from US$ 2.02 billion in 2022 to US$ 3.37 billion by 2030. Global veterinary imaging market revenues will reach US$ 3.37 Billion by 2030, according to a study by Future Market Insights (FMI). The research study analyzes …
Ankylosing Spondylitis Treatment Market is estimated to cross US$ 5.1409 Billion secure a CAGR of 4.6% through 2032
By 2032, it is anticipated that the Ankylosing Spondylitis Treatment Market would reach US$ 5.1409 billion. Through 2032, the market for treating ankylosing spondylitis is anticipated to grow at a CAGR of 4.6%. The market for treating ankylosing spondylitis is anticipated to reach US$ 8.06 billion in 2022. The market for treating ankylosing spondylitis is …
Manual Resuscitator Market | Covidien Plc, Hopkins Medical Product, Drager Medical AG and Co., Laerdal Medical | By 2030
According to research by ESOMAR-certified company Future Market Insights, the global Manual Resuscitator Market is expected to reach a valuation of USD 845.3 million by 2030. (FMI). in a recent market research. Breathlessness is the first symptom of COPD (chronic obstructive pulmonary disease), one of the most serious diseases. According to the WHO, the number …
Vaginitis Treatment Drugs Market | Sanofi S.A., Lupin Pharmaceuticals Inc., Dr Reddy’s Laboratories Ltd, Cipla Ltd. | By 2030
In 2022, the Vaginitis Treatment Drugs Market is anticipated to be worth roughly US$ 3.01 billion. By the end of 2030, market growth is anticipated to advance at a 5.2% CAGR and reach US$ 4.52 Billion. Future Market Insight’s latest report on the vaginitis treatment drugs market establishes that growth is anticipated to be positive, registering a …
Injectable Benzodiazepine Market | F. Hoffmann-La Roche Ltd, Hameln pharma ltd, Teva Pharmaceutical Industries Ltd., Accord Healthcare Ltd | By 2032
Sales of Injectable Benzodiazepine Market are predicted to reach $274 million by the end of 2022. Sales of injectable benzodiazepines are predicted to reach US$ 356 million by 2032’s end. From 2022 to 2032, the injectable benzodiazepines market is anticipated to expand at a 2.7% CAGR. Global Injectable Benzodiazepine Market sales are set to reach …
Swab and Viral Transport Medium Market | Cardinal Health Inc., Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Quidel Corporation | By
According to a recent market analysis by FMI, the global Swab and Viral Transport Medium Market might reach over US$ 8.86 billion in 2023. The market might grow at a 5.8% CAGR and reach a value of US$ 15.60 billion by 2033, according to FMI’s forecast. Swabs and viral transport mediums are in higher demand …
Respiratory Pathogen Testing Kits Market is projected to surpass US$ 7,136.8 million record a CAGR of 5.7% through 2033
As per the latest market research conducted by FMI, the global Respiratory Pathogen Testing Kits Market is expected to record a CAGR of 5.7% from 2023 to 2033. In 2023, the market size is projected to reach a valuation of US$ 4083.1 million. By 2033, the valuation is anticipated to reach US$ 7136.8 million. The …
Non-opioid Pain Patches Market is Expanding at a healthy 4.1% CAGR, the size is projected to total US$ 4.4 Billion by 2029
In 2022, sales of Non-opioid Pain Patches Market are anticipated to reach US$ 3.3 billion. By 2029, the market size is expected to reach US$ 4.4 Billion, growing at a robust 4.1% CAGR. In recent years, non-opioid pain patches have gained huge attention of leading industry players due to the addictive risk and safety concerns …
Preterm Birth Prevention and Management Market | Biophar Lifesciences Pvt. Ltd., Jasco Labs (P) Ltd., BSA Pharma Inc., Pfizer Inc | By 2029
The global Preterm Birth Prevention and Management Market is estimated to be worth around US$ 1.41 Billion in 2022. With increasing adoption of preterm birth prevention and management therapeutics across both developed and developing regions, the overall market is anticipated to grow at 10.1% CAGR between 2022 and 2029, totaling a valuation of US$ 2 .78 …